-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - found that expanded coverage decreased the proportion of men with
high prostate-specific antigen (PSA … The researchers estimated the difference between the proportion of men
with high PSA scores after versus … For instance, a visual inspection of a graph of PSA trends for expansion and
non-expansion states in
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - found that expanded coverage decreased the proportion of men with
high prostate-specific antigen (PSA … The researchers estimated the difference between the proportion of men
with high PSA scores after versus … For instance, a visual inspection of a graph of PSA trends for expansion and
non-expansion states in
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - found that expanded coverage decreased the proportion of men with
high prostate-specific antigen (PSA … The researchers estimated the difference between the proportion of men
with high PSA scores after versus … For instance, a visual inspection of a graph of PSA trends for expansion and
non-expansion states in
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - found that expanded coverage decreased the proportion of men with
high prostate-specific antigen (PSA … The researchers estimated the difference between the proportion of men
with high PSA scores after versus … For instance, a visual inspection of a graph of PSA trends for expansion and
non-expansion states in
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/cancer_older_adults.pdf
September 28, 2012 - An 80-year-old man with
a high prostate-specific antigen (PSA) and biopsy-proven
prostate cancer (true
-
www.ahrq.gov/sites/default/files/2024-11/stafford-fortmann-report.pdf
January 01, 2024 - conclusions because some tests appear to be
underutilized (cholesterol testing) whereas others are overused (PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-draft-report.pdf
December 01, 2024 - 41,516 (51,8% female) ages 20 to 93 years;
Race/ethnicity NR
Protein panel AFP, CA 15-3,
CA 125, PSA … Results
16
reported; PSA = prostate-specific antigen; ROB = risk of bias; SCC = squamous cell specific … 41,516 adults in Taiwan, Wen et al. evaluated an eight protein marker panel
(AFP, CA 15-3, CA 125, PSA … PMA Premarket Approval
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PSA
-
effectivehealthcare.ahrq.gov/products/weight-gain-prevention/research-protocol
October 25, 2011 - gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA
-
effectivehealthcare.ahrq.gov/products/celiac-disease/research-protocol
June 11, 2014 - some tests that have continuous outcomes and possibly multiple cutoffs [e.g., gene expression, serum PSA
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017308-samore-final-report-2011.pdf
January 01, 2011 - including immunizations received and screening tests, such as mammograms or
prostate specific antigen (PSA
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - gain is associated with an increased
risk of prostate cancer recurrence after prostatectomy in the PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - gain is associated with an increased
risk of prostate cancer recurrence after prostatectomy in the PSA
-
effectivehealthcare-admin.ahrq.gov/products/celiac-disease/research-protocol
December 01, 2020 - some tests that have continuous outcomes and possibly multiple cutoffs [e.g., gene expression, serum PSA
-
effectivehealthcare-admin.ahrq.gov/products/weight-gain-prevention/research-protocol
December 01, 2019 - gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026544-devine-final-report-2022.pdf
January 01, 2022 - We further performed a probabilistic
sensitivity analysis (PSA) by varying all parameters using plausible
-
staging-meps.ahrq.gov/survey_comp/hc_survey/2011/MEPS_Spanish_Translation_CI_to_Workgroup.shtml
January 01, 2011 - He went for a routine physical and found out he had cancer
as a result of a PSA test.
-
meps.ahrq.gov/survey_comp/hc_survey/2011/MEPS_Spanish_Translation_CI_to_Workgroup.shtml
January 01, 2011 - He went for a routine physical and found out he had cancer
as a result of a PSA test.
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs021797-gillespie-final-report-2015.pdf
January 01, 2015 - With the advent of widespread use of prostate-specific antigen (PSA) for screening,
along with greater
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - For example, serum levels of prostate-specific antigen (PSA) are reported as a number that will theoretically … This dose-response association can help support the use of serum PSA in detecting prostate cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
June 01, 2012 - For example, serum levels of prostate-specific antigen (PSA) are reported as a number that will theoretically … This dose-response association can help support the use of serum PSA in detecting prostate cancer.